Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland

被引:53
作者
Bardin, A. [1 ,2 ]
Vaccayella, S. [3 ]
Cliffoyd, G. M. [3 ]
Lissowska, J. [1 ,2 ]
Rekosz, M. [1 ,2 ]
Bobkiewicz, P. [1 ,2 ]
Kupryjanczyk, J. [1 ,2 ]
Krynicki, R. [2 ]
Jonska-Gmyrek, J. [1 ,2 ]
Danska-Bidzinska, A. [1 ,2 ]
Snijders, P. J. F. [4 ]
Meijer, C. J. L. M. [4 ]
Zatonski, W. [1 ,2 ]
Franceschi, S. [3 ]
机构
[1] Maria Sklodowska Curie Mem Canc Ctr, PL-02781 Warsaw, Poland
[2] Inst Oncol, PL-02781 Warsaw, Poland
[3] Int Agcy Res Canc, F-69372 Lyon 08, France
[4] Vrije Univ Amsterdam, Med Ctr, NL-1081 HV Amsterdam, Netherlands
关键词
human papillomavirus; cervical cancer; Poland; epidemiology;
D O I
10.1016/j.ejca.2007.12.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cervical cancer incidence and mortality in Poland is among the highest in Europe. To investigate infection with different human papillomaviruses (HPV) in Warsaw, Poland, we obtained cervical cell specimens from 834 women aged 18-59 years from the general population, and 88 cervical cancers. DNA of 44 HPV types was detected using a GP5+/6+-based PCR assay HPV prevalence was 16.6% in the general female population, being highest (24.2%) in women aged 25-34 years, notably among unmarried women (37.3%). HPV prevalence fell to 8.6% at ages 55-59. High-risk HPV prevalence was 11.3%, with HPV16 being the most common type (3.7%). All but one cervical cancer were high-risk HPV-positive, although the importance of HPV16 (73%) was much greater, and multiple infections fewer (1%), than among HPV-positive women in the general female population. In summary, we report a relatively high burden of HPV infection in Warsaw, Poland, where 79% of cervical cancers are theoretically preventable by HPV16/18 vaccines. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:557 / 564
页数:8
相关论文
共 26 条
[1]   Worldwide distribution of human papillomavirus types in cytologically normal women in the international Agency for Research on Cancer HPV prevalence surveys:: a pooled analysis [J].
Clifford, GM ;
Gallus, S ;
Herrero, R ;
Muñoz, N ;
Snijders, PJF ;
Vaccarella, S ;
Anh, PTH ;
Ferreccio, C ;
Hieu, NT ;
Matos, E ;
Molano, M ;
Rajkumar, R ;
Ronco, G ;
de Sanjosé, S ;
Shin, HR ;
Sukvirach, S ;
Thomas, JO ;
Tunsakul, S ;
Meijer, CJLM ;
Franceschi, S .
LANCET, 2005, 366 (9490) :991-998
[2]   Overview of the European and North American studies on HPV testing in primary cervical cancer screening [J].
Cuzick, Jack ;
Clavel, Christine ;
Petry, Karl-Ulrich ;
Meijer, Chris J. L. M. ;
Hoyer, Heike ;
Ratnam, Samuel ;
Szarewski, Anne ;
Birembaut, Philippe ;
Kulasingam, Shalini ;
Sasieni, Peter ;
Iftner, Thomas .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (05) :1095-1101
[3]  
Dybikowska A, 2002, ONCOL REP, V9, P871
[4]   Re: A study of the impact of adding HPV types to cervical cancer screening and triage tests [J].
Franceschi, S ;
Clifford, GM .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (12) :938-939
[5]   Variations in the age-specific curves of human papillomavirus prevalence in women worldwide [J].
Franceschi, Silvia ;
Herrero, Rolando ;
Clifford, Gary M. ;
Snijders, Peter J. F. ;
Arslan, Annie ;
Anh, Pham Thi Hoang ;
Bosch, F. Xavier ;
Ferreccio, Catterina ;
Hieu, Nguyen Trong ;
Lazcano-Ponce, Eduardo ;
Matos, Elena ;
Molano, Monica ;
Qiao, You-Lin ;
Rajkumar, Raj ;
Ronco, Guglielmo ;
de Sanjose, Silvia ;
Shin, Hai-Rim ;
Sukvirach, Sukhon ;
Thomas, Jaiye O. ;
Meijer, Chris J. L. M. ;
Munoz, Nubia .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (11) :2677-2684
[6]  
Giuliano AR, 2001, CANCER EPIDEM BIOMAR, V10, P1129
[7]   PROCESSING OF LONG-STORED ARCHIVAL CERVICAL SMEARS FOR HUMAN PAPILLOMAVIRUS DETECTION BY THE POLYMERASE CHAIN-REACTION [J].
HUSMAN, AMD ;
SNIJDERS, PJF ;
STEL, HV ;
VANDENBRULE, AJC ;
MEIJER, CJLM ;
WALBOOMERS, JMM .
BRITISH JOURNAL OF CANCER, 1995, 72 (02) :412-417
[8]  
Jacobs MV, 2000, INT J CANCER, V87, P221, DOI 10.1002/1097-0215(20000715)87:2&lt
[9]  
221::AID-IJC11&gt
[10]  
3.0.CO